Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Wang

Showing results (941-950 of 970) with videos related to

Pageof 97
Sort By:
Journal for Immunotherapy of Cancer|September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor studyClaire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
Acta Pharmacologica Sinica|November 5, 2021
Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomicsWei Feng, Xi Chen, Shao-Xing Guan, et al.
Acta Pharmacologica Sinica|August 2, 2020
Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2Shu Liu, He Huang, Rong-Xin Chen, et al.
The Lancet. Oncology|December 9, 2017
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialManish R Patel, John Ellerton, Jeffrey R Infante, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 26, 2021
Growth, electronic structure and superconductivity of ultrathin epitaxial CoSi<sub>2</sub>filmsYuan Fang, Ding Wang, Peng Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2022
Scalable Synthesis of Monolayer Hexagonal Boron Nitride on Graphene with Giant Bandgap RenormalizationPing Wang, Woncheol Lee, Joseph P Corbett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib StudyAndrea B Apolo, Jeffrey R Infante, Ani Balmanoukian, et al.
Cell Stem Cell|April 12, 2025
An erythroid-biased FOS<sup>hi</sup> hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxiaWeili Liu, Xiaoru Zhang, Jinhua Liu, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
Pageof 97

Showing results (941-950 of 970) with videos related to

Sort By:
Pageof 97
Journal for Immunotherapy of Cancer|September 10, 2020
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor studyClaire F Verschraegen, Guy Jerusalem, Edward F McClay, et al.
Acta Pharmacologica Sinica|November 5, 2021
Rational application of gefitinib in NSCLC patients with sensitive EGFR mutations based on pharmacokinetics and metabolomicsWei Feng, Xi Chen, Shao-Xing Guan, et al.
Acta Pharmacologica Sinica|August 2, 2020
Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2Shu Liu, He Huang, Rong-Xin Chen, et al.
The Lancet. Oncology|December 9, 2017
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialManish R Patel, John Ellerton, Jeffrey R Infante, et al.
Science Translational Medicine|April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 26, 2021
Growth, electronic structure and superconductivity of ultrathin epitaxial CoSi<sub>2</sub>filmsYuan Fang, Ding Wang, Peng Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 31, 2022
Scalable Synthesis of Monolayer Hexagonal Boron Nitride on Graphene with Giant Bandgap RenormalizationPing Wang, Woncheol Lee, Joseph P Corbett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib StudyAndrea B Apolo, Jeffrey R Infante, Ani Balmanoukian, et al.
Cell Stem Cell|April 12, 2025
An erythroid-biased FOS<sup>hi</sup> hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxiaWeili Liu, Xiaoru Zhang, Jinhua Liu, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysisAndrea B Apolo, John A Ellerton, Jeffrey R Infante, et al.
Pageof 97